🎉 [Gate 30 Million Milestone] Share Your Gate Moment & Win Exclusive Gifts!
Gate has surpassed 30M users worldwide — not just a number, but a journey we've built together.
Remember the thrill of opening your first account, or the Gate merch that’s been part of your daily life?
📸 Join the #MyGateMoment# campaign!
Share your story on Gate Square, and embrace the next 30 million together!
✅ How to Participate:
1️⃣ Post a photo or video with Gate elements
2️⃣ Add #MyGateMoment# and share your story, wishes, or thoughts
3️⃣ Share your post on Twitter (X) — top 10 views will get extra rewards!
👉
The board of directors of the US-listed company Enlivex Therapeutics has approved the purchase of 1 million dollars of BTC as reserve assets.
PANews reported on November 21 that Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a US-listed company, announced yesterday that its board of directors approved the purchase of up to $1 million in Bitcoin as part of its cash management strategy. Oren Hershkovitz, CEO of Enlivex, said, "With the continuous rise in demand for BTC and its increasing acceptance as a recognized Medium of Exchange, we believe that BTC will become a strong and diversified reserve asset for the company. With the recent approval of Bitcoin ETF and increasing support from institutional investors, we believe that BTC can provide the company with potential functional value storage and inflation hedging for standard currency." Enlivex is a clinical-stage macrophage reprogramming immunotherapy company, according to reports.